Some state policies may not protect Medicaid drug selection decisions against conflicts of interests and industry influence, according to a study. FULL STORY »
Sen. Robert Menendez raised concerns with top federal healthcare officials twice in recent years about their finding that a close friend and campaign donor had overbilled the government. FULL STORY »
By Andis Robeznieks | January 22, 2013
| Basic Web
Dr. Irene Aguilar, a Colorado Democratic state legislator, has resigned as a primary-care physician at Denver Health, the state's safety net system anchored by the Denver Health Medical Center, and has taken a seat on the Denver Health and Hospital Authority board of directors. FULL STORY »
The CMS missed its own 2012 deadline to issue the final rule for a regulation that aims to make financial relationships between healthcare providers and manufacturers more transparent. FULL STORY »
A survey of cancer doctors finds that some believe they get paid more when they administer their patients' chemotherapy and other drugs, raising concerns about conflicts of interest and the potential for overtreatment. FULL STORY »
By Andis Robeznieks | December 26, 2012
| Basic Web
Appropriately designed patient-satisfaction surveys "provide robust measures of quality," according to an opinion piece in the New England Journal of Medicine. FULL STORY »
An analysis of a federal investigation of the UC Davis Medical Center—conducted after the deaths of three brain surgery patients at the facility—found that hospital policies and federal regulations were violated, the Sacramento Bee reported Sunday. FULL STORY »
Universal Health Services, King of Prussia, Pa., has won a $6.89 million jury verdict against five former employees and the company they now work for, Acadia Healthcare, Franklin, Tenn. FULL STORY »
Drugmaker Sanofi US will pay $109 million to settle allegations by federal authorities that the company gave away an injectable drug to treat osteoarthritis to doctors who ordered the medication. FULL STORY »
Doctors with financial ties to drug companies have heavily influenced treatment guidelines recommending the most lucrative drugs in American medicine, an analysis finds. FULL STORY »
Switch to the new Modern Healthcare Daily News app
For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.
